Literature DB >> 27060513

Modified Rankin Scale and Short-Term Outcome in Cranial Neurosurgery: A Prospective and Unselected Cohort Study.

Elina Reponen1, Hanna Tuominen2, Juha Hernesniemi3, Miikka Korja3.   

Abstract

BACKGROUND: The modified Rankin Scale (mRS) was developed to monitor functional recovery after stroke, but nowadays it is a treatment outcome measure in elective neurosurgery. Our objective was to study how mRS changes associate with short-term postoperative outcome.
METHODS: Preoperative, in-hospital, and 30-day mRS scores came from a prospective, consecutive and unselected cohort of 418 adult elective craniotomy patients enrolled between December 2011 and December 2012 in Helsinki, Finland. Recorded data included subjective and objective postoperative in-hospital complications as well as changes in mRS score after surgery.
RESULTS: Minor or major complications were detectable in 46% of the patients. In-hospital and 30-day postoperative increases in mRS score were inconsistent; among patients with no complications, 17% had a greater mRS score at discharge and 24% at 30 days, whereas 28% of the patients with major complications showed no increase in mRS score at discharge. Of individual complications, only new or worsened hemiparesis, silent stroke, and pneumonia were associated with postoperative increase (>2) in mRS score after multivariable analysis. For mRS-score difference > 1 at discharge in detecting major complications (including mortality), sensitivity was 45% and specificity 94%.
CONCLUSIONS: The mRS changes after elective cranial neurosurgery are inconsistent. The mRS seems to represent functional changes, which do not necessarily associate with detected in-hospital complications.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Craniotomy; Outcome; modified Rankin Scale

Mesh:

Year:  2016        PMID: 27060513     DOI: 10.1016/j.wneu.2016.03.102

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Evaluation of efficacy and safety of Reteplase and Alteplase in the treatment of hyper-acute cerebral infarction.

Authors:  Zhi-Jian Lin; Hong-Yan Qiu; Xiao-Xin Tong; Yi Guo; Man-Fu Han; Chun-Shui Yang; Kai-Hua Lin; Jun Wu; Xing Li; Yang Yang
Journal:  Biosci Rep       Date:  2018-01-17       Impact factor: 3.840

2.  Bi-frontal pneumocephalus is an independent risk factor for early postoperative agitation in adult patients admitted to intensive care unit after elective craniotomy for brain tumor: A prospective cohort study.

Authors:  Hua-Wei Huang; Li-Mei Yan; Yan-Lin Yang; Xuan He; Xiu-Mei Sun; Yu-Mei Wang; Guo-Bin Zhang; Jian-Xin Zhou
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

3.  Application of neuroendoscopic surgical techniques in the assessment and treatment of cerebral ventricular infection.

Authors:  Feng Guan; Wei-Cheng Peng; Hui Huang; Zu-Yuan Ren; Zhen-Yu Wang; Ji-Di Fu; Ying-Bin Li; Feng-Qi Cui; Bin Dai; Guang-Tong Zhu; Zhi-Yong Xiao; Bei-Bei Mao; Zhi-Qiang Hu
Journal:  Neural Regen Res       Date:  2019-12       Impact factor: 5.135

4.  Comparison of the Functional State and Motor Skills of Patients after Cerebral Hemisphere, Ventricular System, and Cerebellopontine Angle Tumor Surgery.

Authors:  Stanisław Krajewski; Jacek Furtak; Monika Zawadka-Kunikowska; Michał Kachelski; Marcin Birski; Marek Harat
Journal:  Int J Environ Res Public Health       Date:  2022-02-17       Impact factor: 3.390

5.  Rehabilitation Outcomes for Patients with Motor Deficits after Initial and Repeat Brain Tumor Surgery.

Authors:  Stanisław Krajewski; Jacek Furtak; Monika Zawadka-Kunikowska; Michał Kachelski; Marcin Birski; Marek Harat
Journal:  Int J Environ Res Public Health       Date:  2022-08-31       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.